{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:03:14Z","timestamp":1791453794797,"version":"4.3.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-023-05359-5","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T14:02:32Z","timestamp":1701871352000},"page":"929-938","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS\/CFSPID subjects in preschool and school age"],"prefix":"10.1007","volume":"183","author":[{"given":"C.","family":"Fevola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dolce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Dacc\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Claut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Schgor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Timpano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Fabrizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Piccinini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Taccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bonomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Terlizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"key":"5359_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jcf.2006.05.008","volume":"6","author":"Southern KW, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J, Castellani C; ECFS CF Neonatal Screening Working Group","year":"2007","unstructured":"Southern KW, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J, Castellani C; ECFS CF Neonatal Screening Working Group (2007) A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros 6:57\u201365. https:\/\/doi.org\/10.1016\/j.jcf.2006.05.008","journal-title":"J Cyst Fibros"},{"key":"5359_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5694\/mja11.10686","volume":"196","author":"RJ Massie","year":"2012","unstructured":"Massie RJ, Curnow L, Glazner J, Armstrong DS, Francis I (2012) Lessons learned from 20 years of newborn screening for cystic fibrosis. Med J Aust 196:67\u201370. https:\/\/doi.org\/10.5694\/mja11.10686","journal-title":"Med J Aust"},{"key":"5359_CR3","doi-asserted-by":"publisher","first-page":"S255","DOI":"10.1007\/s10545-010-9117-3","volume":"33","author":"JE Hale","year":"2010","unstructured":"Hale JE, Parad RB, Dorkin HL, Gerstle R, Lapey A, O\u2019Sullivan BP, Spencer T, Yee W, Comeau AM (2010) Cystic fibrosis newborn screening: using experience to optimize the screening algorithm. J Inherit Metab Dis 33:S255\u2013S261. https:\/\/doi.org\/10.1007\/s10545-010-9117-3","journal-title":"J Inherit Metab Dis"},{"key":"5359_CR4","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.jpeds.2009.09.003","volume":"155","author":"C Fibrosis","year":"2009","unstructured":"Fibrosis C, Foundation; Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, Rock MJ, Farrell PM, Sontag MK, Rosenfeld M, Davis SD, et al (2009) Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr 155:S106\u2013S116. https:\/\/doi.org\/10.1016\/j.jpeds.2009.09.003","journal-title":"J Pediatr"},{"key":"5359_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jcf.2015.01.001","volume":"14","author":"Munck A, Mayell SJ, Winters V, Shawcross A, Derichs N, Parad R, Barben J, Southern KW; ECFS Neonatal Screening Working Group","year":"2015","unstructured":"Munck A, Mayell SJ, Winters V, Shawcross A, Derichs N, Parad R, Barben J, Southern KW; ECFS Neonatal Screening Working Group (2015) Cystic fibrosis screen positive, inconclusive diagnosis (CFSPID): a new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening. J Cyst Fibros 14:706\u2013713. https:\/\/doi.org\/10.1016\/j.jcf.2015.01.001","journal-title":"J Cyst Fibros"},{"key":"5359_CR6","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.jpeds.2016.09.066","volume":"181S","author":"CL Ren","year":"2017","unstructured":"Ren CL, Borowitz DS, Gonska T, Howenstine MS, Levy H, Massie J, Milla C, Munck A, Southern KW (2017) Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome and cystic fibrosis screen positive, inconclusive diagnosis. J Pediatr 181S:S45\u2013S51. https:\/\/doi.org\/10.1016\/j.jpeds.2016.09.066","journal-title":"J Pediatr"},{"key":"5359_CR7","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jcf.2021.03.015","volume":"20","author":"V Terlizzi","year":"2021","unstructured":"Terlizzi V, Claut L, Tosco A, Colombo C, Raia V, Fabrizzi B, Lucarelli M, Angeloni A, Cimino G, Castaldo A et al (2021) A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS\/CFSPID) in six Italian centres. J Cyst Fibros 20:828\u2013834. https:\/\/doi.org\/10.1016\/j.jcf.2021.03.015","journal-title":"J Cyst Fibros"},{"key":"5359_CR8","doi-asserted-by":"publisher","unstructured":"Munck A, Berger DO, Southern KW, Carducci C, de Winter-de Groot KM, Gartner S, Kashirskaya N, Linnane B, Proesmans M, Sands D, European CF Society Neonatal Screening Working Group (ECFS NSWG) et al (2022) European survey of newborn bloodspot screening for CF: opportunity to address challenges and improve performance. J Cyst Fibros 10:S1569\u20131993. https:\/\/doi.org\/10.1016\/j.jcf.2022.09.012","DOI":"10.1016\/j.jcf.2022.09.012"},{"key":"5359_CR9","doi-asserted-by":"publisher","unstructured":"Bianchimani C, Dolce D, Centrone C, Campana S, Ravenni N, Orioli T, Camera E, Mergni G, Fevola C, Bonomi P, Taccetti G, Terlizzi V (2022) Impact of pancreatitis-associated protein on newborn screening outcomes and detection of CFTR-related metabolic syndrome (CRMS)\/cystic fibrosis screen positive, inconclusive diagnosis (CFSPID): a monocentric prospective pilot experience. Int J Neonatal Screen 8:46. https:\/\/doi.org\/10.3390\/ijns8030046","DOI":"10.3390\/ijns8030046"},{"key":"5359_CR10","doi-asserted-by":"publisher","unstructured":"Barben J, Castellani C, Munck A, Davies JC, de Winter-de Groot KM, Gartner S, Kashirskaya N, Linnane B, Mayell SJ, McColley S, European CF Society Neonatal Screening Working Group (ECFS NSWG) et al (2021) Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome\/cystic fibrosis screen positive, inconclusive diagnosis (CRMS\/CFSPID). J Cyst Fibros 20:810\u2013819. https:\/\/doi.org\/10.1016\/j.jcf.2020.11.006","DOI":"10.1016\/j.jcf.2020.11.006"},{"key":"5359_CR11","doi-asserted-by":"publisher","unstructured":"Gonska T, Keenan K, Au J, Dupuis A, Chilvers MA, Burgess C, Bjornson C, Fairservice L, Brusky J, Kherani T et al (2021) Outcomes of cystic fibrosis screening-positive infants with inconclusive diagnosis at school age. Pediatrics 1(148):e2021051740.\u00a0https:\/\/doi.org\/10.1542\/peds.2021-051740","DOI":"10.1542\/peds.2021-051740"},{"key":"5359_CR12","doi-asserted-by":"publisher","first-page":"e1377","DOI":"10.1542\/peds.2014-2081","volume":"135","author":"CY Ooi","year":"2015","unstructured":"Ooi CY, Castellani C, Keenan K, Avolio J, Volpi S, Boland M, Kovesi T, Bjornson C, Chilvers MA, Morgan L et al (2015) Inconclusive diagnosis of cystic fibrosis after newborn screening. Pediatrics 135:e1377\u2013e1385. https:\/\/doi.org\/10.1542\/peds.2014-2081","journal-title":"Pediatrics"},{"key":"5359_CR13","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/S1569-1993(11)60014-3","volume":"10","author":"C Bombieri","year":"2011","unstructured":"Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, Sermet I, Schwarz M, Tzetis M, Wilschanski M et al (2011) Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros 10:S86-102. https:\/\/doi.org\/10.1016\/S1569-1993(11)60014-3","journal-title":"J Cyst Fibros"},{"key":"5359_CR14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jcf.2022.09.011","volume":"21","author":"Castellani C, De Boeck K, De Wachter E, Sermet-Gaudelus I, Simmonds NJ, Southern KW; ECFS Diagnostic Network Working Group","year":"2022","unstructured":"Castellani C, De Boeck K, De Wachter E, Sermet-Gaudelus I, Simmonds NJ, Southern KW; ECFS Diagnostic Network Working Group (2022) ECFS standards of care on CFTR-related disorders: updated diagnostic criteria. J Cyst Fibros 21:908\u2013921. https:\/\/doi.org\/10.1016\/j.jcf.2022.09.011","journal-title":"J Cyst Fibros"},{"key":"5359_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijns5020023","volume":"15","author":"F Johnson","year":"2019","unstructured":"Johnson F, Southern KW, Ulph F (2019) Psychological impact on parents of an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis: a qualitative study. Int J Neonatal Screen 15:23. https:\/\/doi.org\/10.3390\/ijns5020023","journal-title":"Int J Neonatal Screen"},{"key":"5359_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/children10020177","volume":"10","author":"A Tosco","year":"2023","unstructured":"Tosco A, Marino D, Polizzi S, Tradati V, Padoan R, Giust C, Fabrizzi B, Taccetti G, Merli L, Terlizzi V (2023) A multicentre Italian study on the psychological impact of an inconclusive cystic fibrosis diagnosis after positive neonatal screening. Children (Basel) 10:177. https:\/\/doi.org\/10.3390\/children10020177","journal-title":"Children (Basel)"},{"key":"5359_CR17","doi-asserted-by":"publisher","first-page":"S1569","DOI":"10.1016\/j.jcf.2022.12.002","volume":"15","author":"DK Ginsburg","year":"2022","unstructured":"Ginsburg DK, Salinas DB, Cosanella TM, Wee CP, Saeed MM, Keens TG, Gold JI (2022) High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results. J Cyst Fibros 15:S1569-1993. https:\/\/doi.org\/10.1016\/j.jcf.2022.12.002","journal-title":"J Cyst Fibros"},{"key":"5359_CR18","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1002\/ppul.25683","volume":"56","author":"V Terlizzi","year":"2021","unstructured":"Terlizzi V, Claut L, Colombo C, Tosco A, Castaldo A, Fabrizzi B, Lucarelli M, Cimino G, Carducci C, Dolce D et al (2021) Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome\/CF screen-positive, inconclusive diagnosis. Pediatr Pulmonol 56:3785\u20133791. https:\/\/doi.org\/10.1002\/ppul.25683","journal-title":"Pediatr Pulmonol"},{"key":"5359_CR19","unstructured":"The Sweat Test Recommendations from Italian Cystic Fibrosis Society (SIFC) Sweat Test Working Group\u2014Third Ed. (2022) Available online: https:\/\/www.sifc.it\/wp-content\/uploads\/2022\/06\/Raccomandazioni-Italiane-sul-Test-del-Sudore-_Aprile-2022.pdf . Accessed on 31 May 2023"},{"key":"5359_CR20","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00467-013-2712-4","volume":"29","author":"E Scurati-Manzoni","year":"2014","unstructured":"Scurati-Manzoni E, Fossali EF, Agostoni C, Riva E, Simonetti GD, Zanolari-Calderari M, Bianchetti MG, Lava SA (2014) Electrolyte abnormalities in cystic fibrosis: systematic review of the literature. Pediatr Nephrol 29:1015\u20131023. https:\/\/doi.org\/10.1007\/s00467-013-2712-4","journal-title":"Pediatr Nephrol"},{"key":"5359_CR21","doi-asserted-by":"publisher","unstructured":"Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M et al (2017) Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation. J Pediatr. 181S:S4-S15.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.09.064","DOI":"10.1016\/j.jpeds.2016.09.064"},{"key":"5359_CR22","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/S1569-1993(11)60014-3","volume":"2","author":"C Bombieri","year":"2011","unstructured":"Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, Sermet I, Schwarz M, Tzetis M, Wilschanski M et al (2011) Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros Suppl 2:S86-102. https:\/\/doi.org\/10.1016\/S1569-1993(11)60014-3","journal-title":"J Cyst Fibros Suppl"},{"key":"5359_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jpeds.2007.03.002","volume":"151","author":"VA LeGrys","year":"2007","unstructured":"LeGrys VA, Yankaskas JR, Quittell LM, Marshall BC, Mogayzel PJ Jr, Foundation CF, Foundation CF (2007) Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines. J Pediatr 151:85\u201389. https:\/\/doi.org\/10.1016\/j.jpeds.2007.03.002","journal-title":"J Pediatr"},{"key":"5359_CR24","doi-asserted-by":"publisher","first-page":"1901302","DOI":"10.1183\/13993003.01302-2019","volume":"55","author":"P Anagnostopoulou","year":"2020","unstructured":"Anagnostopoulou P, Latzin P, Jensen R, Stahl M, Harper A, Yammine S, Usemann J, Foong RE, Spycher B, Hall GL et al (2020) Normative data for multiple breath washout outcomes in school-aged Caucasian children. Eur Respir J 55:1901302. https:\/\/doi.org\/10.1183\/13993003.01302-2019","journal-title":"Eur Respir J"},{"key":"5359_CR25","doi-asserted-by":"publisher","unstructured":"Hardaker KM, Panda H, Hulme K, Wong A, Coward E, Cooper P, Fitzgerald DA, Pandit C, Towns S, Selvadurai H, Robinson PD (2019) Abnormal preschool lung clearance index (LCI) reflects clinical status and predicts lower spirometry later in childhood in cystic fibrosis. J Cyst Fibros 18:721\u2013727. https:\/\/doi.org\/10.1016\/j.jcf.2019.02.007","DOI":"10.1016\/j.jcf.2019.02.007"},{"key":"5359_CR26","doi-asserted-by":"publisher","first-page":"1700433","DOI":"10.1183\/13993003.00433-2017","volume":"50","author":"E Oude Engberink","year":"2017","unstructured":"Oude Engberink E, Ratjen F, Davis SD, Retsch-Bogart G, Amin R, Stanojevic S (2017) Inter-test reproducibility of the lung clearance index measured by multiple breath washout. Eur Respir J 50:1700433. https:\/\/doi.org\/10.1183\/13993003.00433-2017","journal-title":"Eur Respir J"},{"key":"5359_CR27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1034\/j.1399-3003.2000.16d28.x","volume":"16","author":"U Frey","year":"2000","unstructured":"Frey U, Stocks J, Coates A, Sly P, Bates J (2000) Specifications for equipment used for infant pulmonary function testing. ERS\/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society\/ American Thoracic Society. Eur Respir J 16:731\u2013740. https:\/\/doi.org\/10.1034\/j.1399-3003.2000.16d28.x","journal-title":"Eur Respir J"},{"key":"5359_CR28","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/children9111625","volume":"9","author":"V Terlizzi","year":"2022","unstructured":"Terlizzi V, Parisi GF, Ferrari B, Castellani C, Manti S, Leonardi S, Taccetti G (2022) Effect of dornase alfa on the lung clearance index in children with cystic fibrosis: a lesson from a case series. Children (Basel) 9:1625. https:\/\/doi.org\/10.3390\/children9111625","journal-title":"Children (Basel)"},{"key":"5359_CR29","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","volume":"180","author":"PA Flume","year":"2009","unstructured":"Flume PA, Mogayzel PJ Jr, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, Marshall BC (2009) Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 180:802\u2013808. https:\/\/doi.org\/10.1164\/rccm.200812-1845PP","journal-title":"Am J Respir Crit Care Med"},{"key":"5359_CR30","doi-asserted-by":"publisher","unstructured":"Beydon N, Davis SD, Lombardi E, Allen JL, Arets HG, Aurora P, Bisgaard H, Davis GM, Ducharme FM, Eigen H, American Thoracic Society\/European Respiratory Society Working Group on Infant and Young Children Pulmonary Function Testing et al (2007) An official American Thoracic Society\/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 175:1304\u201345. https:\/\/doi.org\/10.1164\/rccm.200605-642ST","DOI":"10.1164\/rccm.200605-642ST"},{"key":"5359_CR31","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/ppul.24634","volume":"55","author":"Munck A, Bourmaud A, Bellon G, Picq P, Farrell PM; DPAM Study Group","year":"2020","unstructured":"Munck A, Bourmaud A, Bellon G, Picq P, Farrell PM; DPAM Study Group (2020) Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening. Pediatr Pulmonol 55:918\u2013928. https:\/\/doi.org\/10.1002\/ppul.24634","journal-title":"Pediatr Pulmonol"},{"key":"5359_CR32","doi-asserted-by":"publisher","first-page":"1127659","DOI":"10.3389\/fped.2023.1127659","volume":"11","author":"MA Gunnett","year":"2023","unstructured":"Gunnett MA, Baker E, Mims C, Self ST, Gutierrez HH, Guimbellot JS (2023) Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis\/CFTR related metabolic syndrome. Front Pediatr 11:1127659. https:\/\/doi.org\/10.3389\/fped.2023.1127659","journal-title":"Front Pediatr"},{"key":"5359_CR33","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.jcf.2021.06.012","volume":"21","author":"D Ginsburg","year":"2022","unstructured":"Ginsburg D, Wee CP, Reyes MC, Brewington JJ, Salinas DB (2022) When CFSPID becomes CF. J Cyst Fibros 21:e23\u2013e27. https:\/\/doi.org\/10.1016\/j.jcf.2021.06.012","journal-title":"J Cyst Fibros"},{"key":"5359_CR34","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jcf.2022.04.020","volume":"21","author":"A Tosco","year":"2022","unstructured":"Tosco A, Castaldo A, Colombo C, Claut L, Carnovale V, Iacotucci P, Lucarelli M, Cimino G, Fabrizzi B, Caporelli N et al (2022) Clinical outcomes of a large cohort of individuals with the F508del\/5T;TG12 CFTR genotype. J Cyst Fibros 21:850\u2013855. https:\/\/doi.org\/10.1016\/j.jcf.2022.04.020","journal-title":"J Cyst Fibros"},{"key":"5359_CR35","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/diagnostics10121080","volume":"10","author":"V Terlizzi","year":"2020","unstructured":"Terlizzi V, Padoan R, Claut L, Colombo C, Fabrizzi B, Lucarelli M, Bruno SM, Castaldo A, Bonomi P, Taccetti G, Tosco A (2020) CRMS\/CFSPID subjects carrying D1152H CFTR variant: can the second variant be a predictor of disease development? Diagnostics (Basel) 10:1080. https:\/\/doi.org\/10.3390\/diagnostics10121080","journal-title":"Diagnostics (Basel)"},{"key":"5359_CR36","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/ppul.24721","volume":"55","author":"V Terlizzi","year":"2020","unstructured":"Terlizzi V, Mergni G, Centrone C, Festini F, Taccetti G (2020) Trend of sweat chloride values in a cohort of patients carrying CFTR mutations of varying clinical consequence: is there a risk of increasing sweat chloride over time? Pediatr Pulmonol 55:1089\u20131093. https:\/\/doi.org\/10.1002\/ppul.24721","journal-title":"Pediatr Pulmonol"},{"key":"5359_CR37","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jcf.2021.12.010","volume":"21","author":"A Hatton","year":"2022","unstructured":"Hatton A, Bergougnoux A, Zybert K, Chevalier B, Mesbahi M, Alt\u00e9ri JP, Walicka-Serzysko K, Postek M, Taulan-Cadars M, Edelman A et al (2022) Reclassifying inconclusive diagnosis after newborn screening for cystic fibrosis. Moving forward J Cyst Fibros 21:448\u2013455. https:\/\/doi.org\/10.1016\/j.jcf.2021.12.010","journal-title":"Moving forward J Cyst Fibros"},{"key":"5359_CR38","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/ppul.26296","volume":"58","author":"DB Salinas","year":"2023","unstructured":"Salinas DB, Ginsburg DK, Wee CP, Saeed MM, Brewington JJ (2023) Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS\/CFSPID to CF reclassification. Pediatr Pulmonol 58:1074\u20131084. https:\/\/doi.org\/10.1002\/ppul.26296","journal-title":"Pediatr Pulmonol"},{"key":"5359_CR39","doi-asserted-by":"publisher","unstructured":"Terlizzi V, Fevola C, Ferrari B, Castellani C, Santini G, Innocenti D, Masi E, Bonomi P, Lombardi E, Taccetti G (2023) Lung clearance index in children with cystic fibrosis previously diagnosed with CRMS\/CFSPID: a monocentric prospective experience. Pediatr Pulmonol. https:\/\/doi.org\/10.1002\/ppul.26442. Epub ahead of print. PMID: 37133232","DOI":"10.1002\/ppul.26442"},{"key":"5359_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00408-019-00307-3","volume":"198","author":"AS Kasi","year":"2020","unstructured":"Kasi AS, Wee CP, Keens TG, Salinas DB (2020) Abnormal lung clearance index in cystic fibrosis screen positive, inconclusive diagnosis (CFSPID) children with otherwise normal FEV1. Lung 198:163\u2013167. https:\/\/doi.org\/10.1007\/s00408-019-00307-3","journal-title":"Lung"},{"key":"5359_CR41","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1164\/rccm.200911-1646OC","volume":"183","author":"P Aurora","year":"2011","unstructured":"Aurora P, Stanojevic S, Wade A, Oliver C, Kozlowska W, Lum S, Bush A, Price J, Carr SB, Shankar A, Stocks J, Collaboration LCF (2011) Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med 183:752\u2013758. https:\/\/doi.org\/10.1164\/rccm.200911-1646OC","journal-title":"Am J Respir Crit Care Med"},{"key":"5359_CR42","doi-asserted-by":"publisher","unstructured":"Bauer SE, Wesson M, Oles SK, Ren CL (2021) Outcomes of repeat sweat testing in cystic fibrosis newborn screen positive infants. Pediatr Pulmonol 56:1521\u20131526. https:\/\/doi.org\/10.1002\/ppul.25296","DOI":"10.1002\/ppul.25296"},{"key":"5359_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jcf.2016.11.008","volume":"16","author":"F Vermeulen","year":"2017","unstructured":"Vermeulen F, Lebecque P, De Boeck K, Leal T (2017) Biological variability of the sweat chloride in diagnostic sweat tests: a retrospective analysis. J Cyst Fibros 16:30\u201335. https:\/\/doi.org\/10.1016\/j.jcf.2016.11.008","journal-title":"J Cyst Fibros"},{"key":"5359_CR44","doi-asserted-by":"publisher","first-page":"S1569","DOI":"10.1016\/j.jcf.2023.04.018","volume":"26","author":"V Terlizzi","year":"2023","unstructured":"Terlizzi V, Dolce D (2023) Variability of the sweat test in children with cystic fibrosis previously CRMS\/CFSPID: a retrospective monocenter experience. J Cyst Fibros 26:S1569-1993. https:\/\/doi.org\/10.1016\/j.jcf.2023.04.018","journal-title":"J Cyst Fibros"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05359-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-023-05359-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05359-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T12:15:06Z","timestamp":1709554506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-023-05359-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["5359"],"URL":"https:\/\/doi.org\/10.1007\/s00431-023-05359-5","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]},"assertion":[{"value":"13 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Regional Ethics Committee for Clinical Trials of the Tuscany Region AOU Meyer-Viale Pieraccini, 24-50139 Florence (Ethics Clearance numbers 140\/2018 on 01\/10\/2018, and 235\/2020 on 05\/10\/2020) and subsequently by all ethical committees of the participating CF centres.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}